RT Journal Article SR Electronic T1 Statin Prescribing in Racial/Ethnic Minority Patients across a Major Guideline Change, 2009-2018 JF The Annals of Family Medicine JO Ann Fam Med FD American Academy of Family Physicians SP 3612 DO 10.1370/afm.21.s1.3612 VO 21 IS Supplement 1 A1 Heintzman, John A1 Kaufmann, Jorge A1 Lucas, Jennifer A1 Boston, David A1 Bailey, Steffani A1 Marino, Miguel YR 2023 UL http://www.annfammed.org/content/21/Supplement_1/3612.abstract AB Context: Racial and ethnic minorities in the United States have higher mortality/morbidity from cardiovascular disease (CVD) compared to non-Hispanic whites, and some evidence has suggested that poor risk factor control, including appropriate prescribing of statins for lipid disorders and CVD risk reduction, contributes to these disparities. It is uncertain if the 2013 American Heart Association (AHA)/American College of Cardiology (ACC) guideline change for statin prescription affected this disparity.Objective: To compare the prevalence of patients with guideline indications for statin prescribing, and to compare prescribing prevalence before and after this major guideline change between racial and ethnic groups, by preferred language.Study design: Retrospective, cohort study.Setting/Dataset: A national network of community health centers (CHCs) linked by a common electronic health record dataset.Population studied: Patients were age 50-73, and had ≥1 primary care visit in 2009-2013 and/or 2014-2018.Outcomes: By period, 1) proportion with period-specific indications for statin initiation 2) proportion with a statin prescription if indicated.Results: In the 2009-2013 period (N=109,330), non-English preferring White (OR=1.41, 95% CI 1.15-1.72), Black (OR=1.25, 95% CI 1.10-1.41), and Latino patients (OR=1.09, 95% CI 1.02-1.16) had higher odds of meeting guideline indications for statins than Non-Hispanic White English preferring patients, and of those meeting indications, all except Black non-English patients had higher odds of statin prescription. In the 2014-2018 period (N=319,094), all groups except Latino English-preferred and White Non-English preferred patients had higher odds of meeting the new guideline indications for statin prescription. Of those meeting indications in this period, Latino English speakers had similar odds of statin prescription as non-Hispanic whites; English preferring Black patients had lower odds (OR=0.95, 95% CI 0.91-0.99).Conclusions: CHCs provide CVD screening and statin prescriptions for thousands of racial, ethnic, and language minorities, even more so than some non-Hispanic white English speakers. However, disparities appeared for English preferring Latino and Black patients after the 2013 ACC/AHA guideline change. The evaluation of major clinical guideline changes should account for their impact on racial and ethnic disparities.